GlaxoSmithKline PLC (NYSE:GSK)

45.73
Delayed Data
As of 4:00pm ET
 +1.58 / +3.58%
Today’s Change
33.53
Today|||52-Week Range
46.86
+3.70%
Year-to-Date

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 45.98, with a high estimate of 59.38 and a low estimate of 38.01. The median estimate represents a +0.54% increase from the last price of 45.73.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.66
Sales
$12.7B
Reporting Date
Feb 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -34.61%
 
 
 
 
 
 
Growthannually -5.52%
 
 
 
 
 
 

Sales

Growthquarterly 2.06%
 
 
 
 
 
 
Growthannually -0.95%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.